Analysis of the benefit of anti-PD-1 monotherapy according to NGS-diagnosed genetic alterations in patients with non-small cell lung cancer
The search for a predictive composite biomarker remains a major issue in the coming years.
Authors
- Zineb Maaradji
- Elizabeth Fabre (ORCID: https://orcid.org/0000-0002-1244-873X)
- Hortense de Saint Basile
- Hélène Blons (ORCID: https://orcid.org/0000-0002-0572-8426)
- Réza Elaidi (ORCID: https://orcid.org/0000-0003-2049-7600)
- Laure Gibault (ORCID: https://orcid.org/0000-0002-0791-074X)
- Rym BenDhiab
Institutions
- Inserm (FR)
- Université Paris Cité (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Européen Georges-Pompidou (FR)
Publication Details
- Journal
- Exploration of Targeted Anti-tumor Therapy
- Published
- 2024-12-18
- DOI
- https://doi.org/10.37349/etat.2024.00283
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.28